Company: RGNT
Filing Date: 2025-02-12
Form Type: DRS/A
Source: 0001213900-25-012299
Chunk: 32

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-02-12
Form: DRS/A
Chunk 32
---
close against the assets securing their borrowings and we could be forced into bankruptcy or liquidation. Any of these events could
result in you losing all or a portion of your investment in our ordinary shares.

Our business, operating results and growth rates may be adversely affected by current or future unfavorable economic and market conditions and adverse developments with respect to financial institutions and associated liquidity risk.

Our business depends on the
economic health of the global economies. If the conditions in the global economies remain uncertain or continue to be volatile, or if
they deteriorate, including as a result of the impact of military conflict, terrorism or other geopolitical events, our business, operating
results and financial condition may be materially adversely affected. Economic weakness, inflation and increases in interest rates, limited
availability of credit, liquidity shortages and constrained capital spending have at times in the past resulted, and may in the future
result, in challenging and delayed sales cycles, slower adoption of new technologies and increased price competition, and could negatively
affect our ability to forecast future periods, which could result in an inability to satisfy demand for our products and a loss of market
share.

In
addition, increases in inflation raise our costs for commodities, labor, materials and services and other costs required to grow and operate
our business, and failure to secure these on reasonable terms may adversely impact our financial condition. Additionally, increases in
inflation, along with the uncertainties surrounding any resurgence of COVID-19, geopolitical developments and global supply chain disruptions,
have caused, and may in the future cause, global economic uncertainty and uncertainty about the interest rate environment, which may make
it more difficult, costly or dilutive for us to secure additional financing. A failure to adequately respond to these risks could have
a material adverse impact on our financial condition, results of operations or cash flows.

There
can be no assurance that future credit and financial market instability and a deterioration in confidence in economic conditions
will not occur. Our general business strategy may be adversely affected by any such economic downturn, liquidity shortages, volatile
business environment or continued unpredictable and unstable market conditions. If equity and credit markets deteriorate, or if
adverse developments are experienced by financial institutions, it may cause short-term liquidity risk and also make any
necessary debt or equity financing more difficult, more costly, more onerous with respect to financial and operating covenants and
more dilutive. Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse
effect on our growth